MedPacto, Inc. (KOSDAQ:235980)
South Korea · Delayed Price · Currency is KRW 2,875.00
-85.00 (-2.87%)
Aug 12, 2026, 1:03 PM KST
MedPacto Market Cap
MedPacto has a market cap or net worth of 101.45 billion as of August 11, 2026. Its market cap has decreased by -28.33% in one year.
Market Cap
101.45B
Enterprise Value
65.29B
Revenue
4.79B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,875.00
ChartMarket Cap Chart
Since December 19, 2019, MedPacto's market cap has decreased from 362.50B to 101.45B, a decrease of -72.01%. That is a compound annual growth rate of -17.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 101.45B | -55.69% |
| Dec 30, 2025 | 228.96B | 50.62% |
| Dec 30, 2024 | 152.01B | -37.48% |
| Dec 28, 2023 | 243.12B | -48.17% |
| Dec 29, 2022 | 469.05B | -60.97% |
| Dec 30, 2021 | 1.20T | -49.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 164.20B |
| NeoImmuneTech | 150.67B |
| Macrogen | 136.82B |
| Genexine | 123.70B |
| Vaxcell-Bio Therapeutics | 103.15B |
| iNtRON Biotechnology | 83.87B |
| Prestige BioPharma | 79.33B |
| Amicogen | 76.65B |